IP Library Granted Patent US 11,001,602
Granted Patent B2
US 11,001,602 · App. 16/171,970 · Granted May 11, 2021

Diarylsulfide backbone containing photolabile protecting groups

Inventor: Klaus-Peter Stengele (Reiskirchen, DE)
Assignee: Roche Diagnostics Operations, Inc.
C07H19/20C07C319/14C07C323/19C07C323/32C07D207/16C07D213/70C07D231/12C07D235/28C07H1/00C07H19/02C07H19/06C07H19/10C07H19/16C07K1/04C07K7/08Y02P20/55
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,001,602
App. No.
16/171,970
Granted
May 11, 2021
Kind
B2
Abstract

The present disclosure relates to photoactivable protecting groups containing a diarylsulfide chromophore, a method for the synthesis thereof and their use as photoactivable protecting groups using maskless photolithography based array synthesis.

Claims (42)

1. A method for preparing a diarylsulfide backbone containing one or more photolabile protecting group(s) according to Formula Ib

wherein Y is S or O, and

A is selected from the group consisting of —CH 2 , —CH 2 —CH 2 —, —CH(CH 3 )—, —CH(CH 3 )—CH 2 —, and

R1 is an unsubstituted or substituted aryl- or heteroaryl-group, and R3 is H, a methyl group or an ethyl group, and

wherein R2 is

or wherein R2 is

wherein R4 is H, or R4 with the —O— of Formula III it connects to is a phosphoramidite, H-phosphonate or phosphate triester, and

wherein R5 is H, OH, a halogen or XR6, wherein X is O or S and R6 is H, an alkyl-group, aryl-group, or R6 with the —O— of Formula III it connects to is a phosphoramidite, phosphodiester, phosphotriester, H-phosphonate or an acetal or silicone moiety, and

wherein B is selected from the group consisting of adenine, cytosine, guanine, thymine, uracil, 2,6-diaminopurine-9-yl, hypoxanthin-9-yl, 5-methylcytosinyl-1-yl, 5-amino-4-imidazolecarboxylic acid-1-yl or 5-amino-4-imidazolecarboxylic acid amide-3-yl, wherein when B is adenine, cytosine or guanine the primary amino group optionally has a protecting group or when B is thymine or uracil at the O 4 position is optionally a protecting group, or

wherein R 2 is

wherein R7 is a natural amino acid, a non-natural amino acid or an amino acid derivative, including but not limited to a- or β-amino acids, and formula Ib comprises a urethane bond consisting of a N-terminal nitrogen of R7, the C═O of Formula IV that the N-terminal nitrogen of R7 connects to, and the —O— of formula Ib that the C═O of Formula IV connects to,

or wherein R2 with the —O— of formula Ib it connects to is a natural amino acid, a non-natural amino acid or an amino acid derivative, forming an ester bond to formula Ib, including but not limited to α- or β-amino acids, attached to A by an ester bond comprising the —O— of formula Ib and a C-terminal C═O of R2,

the method comprising the steps of

a) providing p-diethylbenzene as a starting material;

b) bromination of the phenylring;

c) nitration of the obtained compound in Nitric- and Sulfuric Acid in the position para- to the Bromine;

d) purification and crystallization;

e) hydroxymethylation of the compound at the benzylic position;

f) conversion of the aromatic bromine group to the arylsulfide using thiophenol;

g) purification;

h) conversion of the alcohol to chlorocarbonate; and

i) reaction of the chlorocarbonate with a nucleoside and reaction of the nucleoside with a phosphitylating agent, or

reaction of the chlorocarbonate with an amino acid derivative.

2. The method according to claim 1 , characterized in that R1 is a phenyl-group, a tert-butyl-phenyl group, a 1- or 2-naphthyl-group or a 2-pyridyl-group.

3. The method according to claim 1 , characterized in that A is —CH(CH 3 )—CH 2 —.

4. The method according to claim 1 , characterized in that R3 is H or an ethyl group.

5. A method of forming an array through photolithography, said method comprising contacting a substrate having a site activated by exposure to light with a compound of Formula Ib

wherein Y is S or O, and

A is selected from the group consisting of —CH 2 —, —CH 2 —CH 2 —, —CH(CH 3 )—, —CH(CH 3 )—CH 2 —, and

R1 is an unsubstituted or substituted aryl- or heteroaryl-group, and R3 is H, a methyl group or an ethyl group, and

wherein R2 is

or wherein R2 is

wherein R4 is H, or R4 with the —O— of Formula III it connects to is a phosphoramidite, H-phosphonate or phosphate triester, and

wherein R5 is H, OH, a halogen or XR6, wherein X is O or S and R6 is H, an alkyl-group, aryl-group, or R6 with the —O— of Formula III it connects to is a phosphoramidite, phosphodiester, phosphotriester, H-phosphonate or an acetal or silicone moiety, and

wherein B is selected from the group consisting of adenine, cytosine, guanine, thymine, uracil, 2,6-diaminopurine-9-yl, hypoxanthin-9-yl, 5-methylcytosinyl-1-yl, 5-amino-4-imidazolecarboxylic acid-1-yl or 5-amino-4-imidazolecarboxylic acid amide-3-yl, wherein when B is adenine, cytosine or guanine the primary amino group optionally has a protecting group or when B is thymine or uracil at the 0 4 position is optionally a protecting group, or

wherein R2 is

wherein R7 is a natural amino acid, a non-natural amino acid or an amino acid derivative, including but not limited to a- or β-amino acids, and formula Ib comprises a urethane bond consisting of a N-terminal nitrogen of R7, the C═O of Formula IV that the N-terminal nitrogen of R7 connects to, and the —O— of formula Ib that the C═O of Formula IV connects to,

or wherein R2 with the —O— of formula Ib it connects to is a natural amino acid, a non-natural amino acid or an amino acid derivative, forming an ester bond to formula Ib, including but not limited to α- or β-amino acids, attached to A by an ester bond comprising the —O— of formula Ib and a C-terminal C═O of R2.

6. The method of claim 5 wherein the contacting of the substrate with a compound of Formula Ib produces a DNA microarray or a peptide microarray.

7. The method of claim 6 wherein the method produces a DNA microarray.

8. The method of claim 6 wherein the method produces a peptide microarray.

9. The method of claim 5 wherein the substrate and/or the compound is activated by exposure to light between the wavelengths of 374 to 405 nm.

Assignments (3)
MERGER Recorded May 14, 2019
From: NIMBLEGEN SYSTEMS GMBH
To: ROCHE DIAGNOSTICS GMBH
Reel/Frame 050895/0720 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 14, 2019
From: STENGELE, KLAUS-PETER
To: NIMBLEGEN SYSTEMS GMBH
Reel/Frame 049171/0991 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 14, 2019
From: ROCHE DIAGNOSTICS GMBH
To: ROCHE DIAGNOSTICS OPERATIONS, INC.
Reel/Frame 049172/0115 →
Priority Claims (1)
EP 1161556 · Apr 7, 2011 · regional
Continuity (5)
Division 15425329 · Feb 6, 2017
Continuation 14935516 · Nov 9, 2015
Continuation 14061297 · Oct 23, 2013
Continuation 13433373 · Mar 29, 2012
Related Publication 20190112328A1 · Apr 18, 2019